News summarySEC EDGARNov 4, 2026, 12:00 PM
Zimmer Biomet, 8-K (2.02, 9.01): reported results of operations
Zimmer Biomet reported third-quarter 2026 sales of $2.063 billion, up 3.1% reported and 3.7% constant currency, diluted EPS of $1.00 and adjusted EPS of $1.90, and updated its full-year 2026 financial guidance.